COPLAND ROAD CAPITAL NEW (F:A2P) — Market Cap & Net Worth
Market Cap & Net Worth: COPLAND ROAD CAPITAL NEW (A2P)
COPLAND ROAD CAPITAL NEW (F:A2P) has a market capitalization of $667.40 Million (€570.87 Million) as of September 20, 2026. Listed on the F stock exchange, this Germany-based company holds position #10882 globally and #1254 in its home market, demonstrating a 1.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COPLAND ROAD CAPITAL NEW's stock price €79.45 by its total outstanding shares 8529129 (8.53 Million). Also see A2P current and non-current assets for a full breakdown of the balance sheet.
COPLAND ROAD CAPITAL NEW Market Cap History: 2015 to 2026
COPLAND ROAD CAPITAL NEW's market capitalization history from 2015 to 2026. Data shows growth from $498.57K to $792.23 Million (113.54% CAGR). Also see COPLAND ROAD CAPITAL NEW (A2P) cash flow conversion for how efficiently the company converts equity into cash flow.
COPLAND ROAD CAPITAL NEW Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COPLAND ROAD CAPITAL NEW's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check COPLAND ROAD CAPITAL NEW stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.98x
COPLAND ROAD CAPITAL NEW's market cap is 0.98 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.51x
COPLAND ROAD CAPITAL NEW's market cap is 6.51 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.37 Million | $166.86 Million | $10.30 Million | 0.01x | 0.13x |
| 2023 | $1.50 Million | $446.87 Million | $52.45 Million | 0.00x | 0.03x |
| 2024 | $453.20 Million | $624.12 Million | $82.57 Million | 0.73x | 5.49x |
| 2025 | $669.58 Million | $681.60 Million | $102.93 Million | 0.98x | 6.51x |
Competitor Companies of A2P by Market Capitalization
Companies near COPLAND ROAD CAPITAL NEW in the global market cap rankings as of September 20, 2026. Review COPLAND ROAD CAPITAL NEW tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to COPLAND ROAD CAPITAL NEW by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
COPLAND ROAD CAPITAL NEW Historical Marketcap From 2015 to 2026
Between 2015 and today, COPLAND ROAD CAPITAL NEW's market cap moved from $498.57K to $ 792.23 Million, with a yearly change of 113.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €792.23 Million | +18.32% |
| 2025 | €669.58 Million | +47.74% |
| 2024 | €453.20 Million | +30200.00% |
| 2023 | €1.50 Million | +9.49% |
| 2022 | €1.37 Million | +6.20% |
| 2021 | €1.29 Million | +4200.00% |
| 2020 | €29.91K | -91.18% |
| 2019 | €339.03K | -83.00% |
| 2018 | €1.99 Million | 0.00% |
| 2017 | €1.99 Million | +185.71% |
| 2016 | €698.00K | +40.00% |
| 2015 | €498.57K | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of COPLAND ROAD CAPITAL NEW was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $667.40 Million USD |
| MoneyControl | $667.40 Million USD |
| MarketWatch | $667.40 Million USD |
| marketcap.company | $667.40 Million USD |
| Reuters | $667.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About COPLAND ROAD CAPITAL NEW
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more